Novus Diagnostics

Rapid answers right at the patient's bedside

Dublin, Ireland · Founded 2020 · $19.0M raised

Headquarters
Dublin
Employees
11–50
Founded
2020
Business Model
B2B
Total Funding
$19.0M
Last Round
$5.0M Series AOct 2024
Rounds
3

About

Novus Diagnostics is a Dublin-based medical device company developing ground-breaking point-of-care diagnostics technologies for rapid bedside diagnosis of critical conditions. The company's flagship product, SepTec, is a 15-minute sample-to-answer diagnostic device that detects and characterizes bloodstream infections in whole blood using novel electrochemical sensors, centrifugal microfluidics, and automated sample processing — targeting sepsis, which kills more than 11 million people annually. Founded in 2020, Novus has secured over €7 million in funding from the EU and investors including Trinity Biotech.

Summary

Novus Diagnostics is a Biotech company based in Dublin, Ireland, founded in 2020. It has raised $19.0M in total across 3 rounds, most recently a $5.0M Series A round in Oct 2024. Investors include BVP Ireland and European Innovation Council Fund.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AOct 2024
$5.0M

Sign up to see all 3 rounds

Grant through Series A — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Novus Diagnostics on Indexed.vc
<a href="https://indexed.vc/companies/novus-diagnostics"><img src="https://indexed.vc/api/badge/company/novus-diagnostics" alt="Novus Diagnostics on Indexed.vc" width="260" height="76" /></a>